Skin/Integumentary Applications a Proving Ground of Cell/Tissue Engineering

Burn wounds, diabetic ulcers, venous ulcers and plastic/reconstructive surgery have represented not only a significant caseload but also a sizeable unmet (or ineffectively satisfied) demand historically for treatment via wound management technologies. For this reason, combined with the chronic nature of these conditions, the application of cell therapy and tissue engineering has made skin/integumentary applications a technology proving ground. A current global market in excess of $700 million in skin-related cell and tissue therapies is also demonstrating that the application has room for growth, in all regions of the world.

The MedMarket Diligence report #S520, “Tissue Engineering, Cell Therapy and Transplantation, 2009-2018”, highlights and details the global market for skin/integumentary (and all major) clinical applications of cell therapy and tissue engineering.

The report is described in detail at http://mediligence.com/rpt/rpt-s520.htm and may be purchased for download from https://mediligence.com/store/page32.html.

Posted via email from medmarket’s posterous

Leave a Reply